Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-03-31
DOI
10.1002/alz.12651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microvascular Alterations in Alzheimer's Disease
- (2021) Joe Steinman et al. Frontiers in Cellular Neuroscience
- Role of Interleukin-6 in Vascular Health and Disease
- (2021) Paulina Villar-Fincheira et al. Frontiers in Molecular Biosciences
- Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease
- (2021) Amanda Ferreira Neves et al. EXPERIMENTAL NEUROLOGY
- An Integrated View on Vascular Dysfunction in Alzheimer’s Disease
- (2020) Jan Klohs Neurodegenerative Diseases
- Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease: a meta-analytic review on potential mechanisms
- (2020) Chuan Qin et al. Translational Neurodegeneration
- The Regulatory Role of IL-10 in Neurodegenerative Diseases
- (2020) Chiara Porro et al. Biomolecules
- The IL-2 – IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor
- (2020) Jan Damoiseaux CLINICAL IMMUNOLOGY
- Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer’s Disease
- (2019) Virginia Boccardi et al. Frontiers in Aging Neuroscience
- Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease
- (2019) Elena P. Moreno-Jiménez et al. NATURE MEDICINE
- Interleukin-6 (IL-6) mediates protection against glucose toxicity in human Müller cells via activation of VEGF-A signaling
- (2019) Brandon A. Coughlin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prevention and Treatment of Alzheimer’s Disease: Biological Mechanisms of Exercise
- (2019) Hugo McGurran et al. JOURNAL OF ALZHEIMERS DISEASE
- New Guidelines for Statistical Reporting in the Journal
- (2019) David Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Studies of Cell Therapy in Cardiovascular Medicine
- (2018) Monisha N. Banerjee et al. CIRCULATION RESEARCH
- Effects of mesenchymal stem cells transplantation on cognitive deficits in animal models of Alzheimer’s disease: A systematic review and meta-analysis
- (2018) Meiling Ge et al. Brain and Behavior
- Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2017) Bryon A Tompkins et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
- (2017) Per Johansson et al. PLoS One
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- A computational atlas of the hippocampal formation using ex vivo , ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI
- (2015) Juan Eugenio Iglesias et al. NEUROIMAGE
- The Role of Vascular Endothelial Growth Factor in Neurodegeneration and Cognitive Decline
- (2015) Timothy J. Hohman et al. JAMA Neurology
- IL-4-Induced Selective Clearance of Oligomeric -Amyloid Peptide1-42 by Rat Primary Type 2 Microglia
- (2014) E. Shimizu et al. JOURNAL OF IMMUNOLOGY
- Phase II Clinical Research Design in Cardiology
- (2013) Joshua M. Hare et al. CIRCULATION
- Enhanced Medial Collateral Ligament Healing Using Mesenchymal Stem Cells: Dosage Effects on Cellular Response and Cytokine Profile
- (2013) Erin E. Saether et al. Stem Cell Reviews and Reports
- IL-4 in the Brain: A Cytokine To Remember
- (2012) Sachin P. Gadani et al. JOURNAL OF IMMUNOLOGY
- Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice
- (2012) K. Kawahara et al. NEUROSCIENCE
- Soluble CCL5 Derived from Bone Marrow-Derived Mesenchymal Stem Cells and Activated by Amyloid β Ameliorates Alzheimer's Disease in Mice by Recruiting Bone Marrow-Induced Microglia Immune Responses
- (2012) Jong Kil Lee et al. STEM CELLS
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- What is the clinically relevant change on the ADAS-Cog?
- (2011) Anette Schrag et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Determining the minimum clinically important differences for outcomes in the DOMINO trial
- (2010) Robert Howard et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
- (2009) Joshua M. Hare et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More